Selen Hürmüzlü Közler
Research Subjects
Selen Hürmüzlü Közler has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Ziya Birbilen
Division of Pediatric Emergency, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
1 shared publication Alev Güven
Sağlık Bilimleri Üniversitesi Ankara Çocuk Sağlığı ve Hastalıkları Hematoloji Onkoloji Eğitim ve Araştırma Hastanesi, Çocuk Nöroloji
1 shared publication- Emine Dibek Mısırlıoğlu
Department of Pediatric Allergy/Immunology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Türkiye
1 shared publication Emre Sarıkaya
Department of Pediatric Endocrinology, Kocaeli City Hospital, Kocaeli, Turkey
1 shared publication- Emre Sarıkaya
Department of Pediatric Endocrinology, Erciyes University Faculty of Medicine Hospitals, Kayseri, Turkey
1 shared publication Fatih Kilci
Department of Pediatric Endocrinology, Kocaeli City Hospital, Kocaeli, Turkey
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-6
Extreme leukocytosis is not associated with increased risk of serious bacterial infection in pediatric emergency patients
Objective: Extreme leukocytosis is often considered a warning sign of serious bacterial infection (SBI) in febrile children. However, its diagnostic value remains controversial, particularly in the post-vaccination era. This study aimed to evaluate whether extreme leukocytosis is associated with an increased risk of SBI compared with moderate leukocytosis in pediatric emergency patients. Materials and Methods: This single-center, retrospective comparative study included children aged 1 month to 18 years who presented to a tertiary pediatric emergency department in Ankara, Türkiye, with a white blood cell (WBC) count ≥15.000/mm³. Patients were classified into moderate (15.000–24.999/mm³) and extreme (≥25.000/mm³) leukocytosis groups. SBI frequency, C-reactive protein (CRP) levels, and multivariable predictors of SBI were analyzed. Results: A total of 955 patients were included (423 extreme, 532 moderate leukocytosis). SBI was identified in 26.0% of extreme and 22.7% of moderate leukocytosis patients (p=0.243). In multivariable analysis, extreme leukocytosis was not independently associated with SBI (OR 1.18, 95% CI 0.86–1.61, p=0.308), whereas CRP (OR 1.05, 95% CI 1.02–1.07, p=0.001) and fever (OR 2.21, 95% CI 1.54–3.16, p<0.001) were significant predictors. CRP showed moderate discriminatory ability (AUC 0.649), with improved performance in the extreme leukocytosis subgroup (AUC 0.705). Conclusion: Extreme leukocytosis was not associated with increased SBI risk compared with moderate leukocytosis. CRP provided independent predictive value and may serve as a more useful biomarker for SBI risk stratification in pediatric emergency patients with leukocytosis.
- 18 September 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-6
Open AccessExtreme leukocytosis is not associated with increased risk of serious bacterial infection in pediatric emergency patients
Objective: Extreme leukocytosis is often considered a warning sign of serious bacterial infection (SBI) in febrile children. However, its diagnostic value remains controversial, particularly in the post-vaccination era. This study aimed to evaluate whether extreme leukocytosis is associated with an increased risk of SBI compared with moderate leukocytosis in pediatric emergency patients. Materials and Methods: This single-center, retrospective comparative study included children aged 1 month to 18 years who presented to a tertiary pediatric emergency department in Ankara, Türkiye, with a white blood cell (WBC) count ≥15.000/mm³. Patients were classified into moderate (15.000–24.999/mm³) and extreme (≥25.000/mm³) leukocytosis groups. SBI frequency, C-reactive protein (CRP) levels, and multivariable predictors of SBI were analyzed. Results: A total of 955 patients were included (423 extreme, 532 moderate leukocytosis). SBI was identified in 26.0% of extreme and 22.7% of moderate leukocytosis patients (p=0.243). In multivariable analysis, extreme leukocytosis was not independently associated with SBI (OR 1.18, 95% CI 0.86–1.61, p=0.308), whereas CRP (OR 1.05, 95% CI 1.02–1.07, p=0.001) and fever (OR 2.21, 95% CI 1.54–3.16, p<0.001) were significant predictors. CRP showed moderate discriminatory ability (AUC 0.649), with improved performance in the extreme leukocytosis subgroup (AUC 0.705). Conclusion: Extreme leukocytosis was not associated with increased SBI risk compared with moderate leukocytosis. CRP provided independent predictive value and may serve as a more useful biomarker for SBI risk stratification in pediatric emergency patients with leukocytosis.
- Open Access
- 10 September 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-7
Differentiating Graves disease from Hashitoxicosis in children: Clinical and biochemical predictors
Objective: Differentiating Graves disease (GD) from Hashitoxicosis in children is often challenging due to overlapping clinical and biochemical features at presentation. This study aimed to evaluate the diagnostic utility of commonly available clinical and biochemical parameters to support etiologic classification in pediatric autoimmune thyrotoxicosis. Materials and Methods: We retrospectively analyzed 58 children aged 0–18 years diagnosed with autoimmune thyrotoxicosis between 2019 and 2025. Clinical, laboratory, and imaging findings were compared between patients with GD and Hashitoxicosis. Receiver operating characteristic (ROC) analysis and logistic regression were performed to assess the diagnostic performance of key parameters. Results: The cohort was female-predominant, with similar sex distribution between groups (34/44, 77.3% in GD vs 11/14, 78.6% in Hashitoxicosis). Palpitations were the most common presenting symptom (17, 29.3 %). Incidental detection occurred in 17 (29.3%), of whom 9 (52.9%) had subtle symptoms identified on detailed clinical evaluation. Ophthalmopathy was observed exclusively in GD (13, 29.5%). fT3 levels and the fT3/fT4 ratio were significantly higher in GD than in Hashitoxicosis (p = 0.002 and p = 0.001, respectively). TRAb showed the highest diagnostic performance (AUC = 0.950), followed by fT3 (AUC = 0.856) and the fT3/fT4 ratio (AUC = 0.809). A TRAb cut-off of 2.6 IU/L yielded 75% sensitivity and 100% specificity, whereas fT3 ≥6 pg/mL yielded 93% sensitivity and 46% specificity. Anti-TPO and anti-Tg antibodies showed poor discriminatory value. TRAb remained independently associated with GD (OR = 3.61, p = 0.011). Nine children with Hashitoxicosis (64.3%) were managed without treatment and achieved spontaneous resolution. Conclusion: Differentiating GD from Hashitoxicosis requires an integrated assessment of clinical features, antibody status, and hormone dynamics. TRAb remains the most informative marker, while fT3 and the fT3/fT4 ratio may provide complementary value. Anti-thyroid antibodies have limited utility for etiologic differentiation. Accurate classification helps guide the management and avoid unnecessary treatment.
- 10 September 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- p. 1-7
Open AccessDifferentiating Graves disease from Hashitoxicosis in children: Clinical and biochemical predictors
Objective: Differentiating Graves disease (GD) from Hashitoxicosis in children is often challenging due to overlapping clinical and biochemical features at presentation. This study aimed to evaluate the diagnostic utility of commonly available clinical and biochemical parameters to support etiologic classification in pediatric autoimmune thyrotoxicosis. Materials and Methods: We retrospectively analyzed 58 children aged 0–18 years diagnosed with autoimmune thyrotoxicosis between 2019 and 2025. Clinical, laboratory, and imaging findings were compared between patients with GD and Hashitoxicosis. Receiver operating characteristic (ROC) analysis and logistic regression were performed to assess the diagnostic performance of key parameters. Results: The cohort was female-predominant, with similar sex distribution between groups (34/44, 77.3% in GD vs 11/14, 78.6% in Hashitoxicosis). Palpitations were the most common presenting symptom (17, 29.3 %). Incidental detection occurred in 17 (29.3%), of whom 9 (52.9%) had subtle symptoms identified on detailed clinical evaluation. Ophthalmopathy was observed exclusively in GD (13, 29.5%). fT3 levels and the fT3/fT4 ratio were significantly higher in GD than in Hashitoxicosis (p = 0.002 and p = 0.001, respectively). TRAb showed the highest diagnostic performance (AUC = 0.950), followed by fT3 (AUC = 0.856) and the fT3/fT4 ratio (AUC = 0.809). A TRAb cut-off of 2.6 IU/L yielded 75% sensitivity and 100% specificity, whereas fT3 ≥6 pg/mL yielded 93% sensitivity and 46% specificity. Anti-TPO and anti-Tg antibodies showed poor discriminatory value. TRAb remained independently associated with GD (OR = 3.61, p = 0.011). Nine children with Hashitoxicosis (64.3%) were managed without treatment and achieved spontaneous resolution. Conclusion: Differentiating GD from Hashitoxicosis requires an integrated assessment of clinical features, antibody status, and hormone dynamics. TRAb remains the most informative marker, while fT3 and the fT3/fT4 ratio may provide complementary value. Anti-thyroid antibodies have limited utility for etiologic differentiation. Accurate classification helps guide the management and avoid unnecessary treatment.
- 21 August 2026
- Published by Springer Nature in Journal of Endocrinological Investigation
- p. 1-9
Interpreting the GnRH stimulation test in girls with central precocious puberty: the role of age and body mass index
Purpose The gonadotropin-releasing hormone (GnRH) stimulation test is the reference standard for diagnosing central precocious puberty (CPP), yet its reliability may vary with age and body mass index (BMI). This study evaluated the diagnostic performance of GnRH test parameters in girls with suspected CPP and examined the influence of age and BMI on their clinical interpretation. Methods This retrospective study included 98 girls who underwent GnRH stimulation testing between January 2023 and December 2025 at a tertiary pediatric endocrinology center. Auxological data, basal luteinizing hormone (LH), stimulated LH at 40 min (LH₄₀), stimulated LH/FSH ratio (sLH/FSH), bone age advancement (BAA), and pelvic ultrasonographic measurements were recorded. Final CPP diagnosis based on longitudinal follow-up served as the reference outcome. ROC analyses, age- and BMI-stratified evaluations, and multivariable logistic regression were performed. Results Thirty-six girls (36.7%) were diagnosed with CPP, and all initiated GnRHanalogue treatment. LH₄₀ showed the highest diagnostic performance (AUC = 0.738); a cut-off of 4.65 IU/L yielded 91.2% sensitivity and 61.7% specificity. Basal LH had limited accuracy (AUC = 0.668), and ultrasonographic parameters showed poor discrimination. LH₄₀ and BAA were independently associated with CPP. Diagnostic performance varied by age, with excellent discrimination in girls < 6 years (AUC = 1.000) and moderate accuracy at 6–8 years (AUC = 0.738). Increasing BMI was associated with reduced discriminatory capacity of LH₄₀, while uterine length showed relatively higher performance in girls with obesity. Conclusion The diagnostic performance of the GnRH stimulation test varied with age and BMI and was lower in older girls and those with obesity. LH₄₀ was the most informative hormonal parameter, but should not be interpreted in isolation. Test results should be integrated with clinical progression, auxological findings, skeletal maturation, biochemical data, and imaging when clinically indicated.
- 21 August 2026
- Published by Springer Nature in Journal of Endocrinological Investigation
- p. 1-9
Interpreting the GnRH stimulation test in girls with central precocious puberty: the role of age and body mass index
Purpose The gonadotropin-releasing hormone (GnRH) stimulation test is the reference standard for diagnosing central precocious puberty (CPP), yet its reliability may vary with age and body mass index (BMI). This study evaluated the diagnostic performance of GnRH test parameters in girls with suspected CPP and examined the influence of age and BMI on their clinical interpretation. Methods This retrospective study included 98 girls who underwent GnRH stimulation testing between January 2023 and December 2025 at a tertiary pediatric endocrinology center. Auxological data, basal luteinizing hormone (LH), stimulated LH at 40 min (LH₄₀), stimulated LH/FSH ratio (sLH/FSH), bone age advancement (BAA), and pelvic ultrasonographic measurements were recorded. Final CPP diagnosis based on longitudinal follow-up served as the reference outcome. ROC analyses, age- and BMI-stratified evaluations, and multivariable logistic regression were performed. Results Thirty-six girls (36.7%) were diagnosed with CPP, and all initiated GnRHanalogue treatment. LH₄₀ showed the highest diagnostic performance (AUC = 0.738); a cut-off of 4.65 IU/L yielded 91.2% sensitivity and 61.7% specificity. Basal LH had limited accuracy (AUC = 0.668), and ultrasonographic parameters showed poor discrimination. LH₄₀ and BAA were independently associated with CPP. Diagnostic performance varied by age, with excellent discrimination in girls < 6 years (AUC = 1.000) and moderate accuracy at 6–8 years (AUC = 0.738). Increasing BMI was associated with reduced discriminatory capacity of LH₄₀, while uterine length showed relatively higher performance in girls with obesity. Conclusion The diagnostic performance of the GnRH stimulation test varied with age and BMI and was lower in older girls and those with obesity. LH₄₀ was the most informative hormonal parameter, but should not be interpreted in isolation. Test results should be integrated with clinical progression, auxological findings, skeletal maturation, biochemical data, and imaging when clinically indicated.
- Open Access
- 31 January 2024
- Published by Wiley
FACTORS INFLUENCING INITIATION AND DISCONTINUATION OF VITAMIN D SUPPLEMENTATION AMONG INFANTS
Objectives: To determine vitamin D supplementation frequency among infants, factors that influence adherence, and reasons for discontinuation of initiated vitamin D. Methods: This cross-sectional study was conducted using a questionnaire administered to the mothers via face-to-face interview of 560 infants aged from 1 to 24 months admitted to outpatient clinics from June to December 2017. Results: A total of 351 infants were administered vitamin D, and the rate of supplementation in the first year of life was 83%, while it was only 28% between 13 and 24 months. The rate of vitamin D supplementation was higher among exclusively formula-fed infants (p<.05). When the data were analyzed using logistic regression analysis, only visit family physicians statistically significant independent variable in increasing supplementation (p<.05). Compared with family refusal, the rate of discontinuation of vitamin D by the healthcare providers was higher after the first year of life (p<.05). The rate of vitamin D discontinuation by healthcare providers, especially by nurses who considered the duration of supplementation adequate, was statistically significantly higher when compared with the fontanel closure and other independent variables (p<0.05). Conclusions: The rate of vitamin D supplementation was higher among families who visited family physicians, which suggests the importance of well-baby visits. Since vitamin D supplementation was less common among exclusively breastfed infants, mothers should be educated. Healthcare professionals need further education about the importance of vitamin D supplementation and indications for discontinuation.
- 31 January 2024
- Published by Wiley
Open AccessFACTORS INFLUENCING INITIATION AND DISCONTINUATION OF VITAMIN D SUPPLEMENTATION AMONG INFANTS
Objectives: To determine vitamin D supplementation frequency among infants, factors that influence adherence, and reasons for discontinuation of initiated vitamin D. Methods: This cross-sectional study was conducted using a questionnaire administered to the mothers via face-to-face interview of 560 infants aged from 1 to 24 months admitted to outpatient clinics from June to December 2017. Results: A total of 351 infants were administered vitamin D, and the rate of supplementation in the first year of life was 83%, while it was only 28% between 13 and 24 months. The rate of vitamin D supplementation was higher among exclusively formula-fed infants (p<.05). When the data were analyzed using logistic regression analysis, only visit family physicians statistically significant independent variable in increasing supplementation (p<.05). Compared with family refusal, the rate of discontinuation of vitamin D by the healthcare providers was higher after the first year of life (p<.05). The rate of vitamin D discontinuation by healthcare providers, especially by nurses who considered the duration of supplementation adequate, was statistically significantly higher when compared with the fontanel closure and other independent variables (p<0.05). Conclusions: The rate of vitamin D supplementation was higher among families who visited family physicians, which suggests the importance of well-baby visits. Since vitamin D supplementation was less common among exclusively breastfed infants, mothers should be educated. Healthcare professionals need further education about the importance of vitamin D supplementation and indications for discontinuation.
- 10 December 2021
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 38 (3) , 435-441
Factors influencing initiation and discontinuation of vitamin D supplementation among children 1-24-months-old
To determine vitamin D supplementation frequency among children aged 1 to 24 months, factors that influence adherence, and reasons for discontinuation of initiated vitamin D.This cross-sectional st...
- 10 December 2021
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 38 (3) , 435-441
Factors influencing initiation and discontinuation of vitamin D supplementation among children 1-24-months-old
To determine vitamin D supplementation frequency among children aged 1 to 24 months, factors that influence adherence, and reasons for discontinuation of initiated vitamin D.This cross-sectional st...
- Open Access
- 19 April 2021
- Published by MDPI AG in Preprints.org
Factors Influencing Initiation and Discontinuation of Vitamin D Supplementation Among Infants
Background: To determine vitamin D supplementation frequency among infants, factors that influence adherence, and reasons for discontinuation of initiated vitamin D. Methods: This cross-sectional study was conducted using a questionnaire administered to the mothers via a face-to-face interview on 560 infants aged from 1 to 24 months admitted to outpatient clinics from June to December 2017. Results: A total of 351 infants were administered vitamin D, and the rate of supplementation in the first year of life was 83%, while it was only 28% between 13 and 24 months. The rate of vitamin D supplementation was higher among infants who were exclusively formula-fed (p<.05). When the data were analyzed using logistic regression analysis, only visit family physicians seems to be a statistically significant independent variable in increasing supplementation (p<.05). Compared with family refusal, the rate of discontinuation of vitamin D by the healthcare providers was higher after the first year of life (p<.05). The rates of vitamin D discontinuation by healthcare providers, especially by nurses who considered the duration of supplementation adequate, were statistically significantly higher when compared with the fontanel closure and other reasons (p<0.05). Conclusions: The rate of vitamin D supplementation was higher among families who visited family physicians, which suggests the importance of well-baby visits. Since vitamin D supplementation was less common among exclusively breastfed infants, mothers should be educated. Healthcare professionals need further education about the importance of vitamin D supplementation and indications for discontinuation.
- 19 April 2021
- Published by MDPI AG in Preprints.org
Open AccessFactors Influencing Initiation and Discontinuation of Vitamin D Supplementation Among Infants
Background: To determine vitamin D supplementation frequency among infants, factors that influence adherence, and reasons for discontinuation of initiated vitamin D. Methods: This cross-sectional study was conducted using a questionnaire administered to the mothers via a face-to-face interview on 560 infants aged from 1 to 24 months admitted to outpatient clinics from June to December 2017. Results: A total of 351 infants were administered vitamin D, and the rate of supplementation in the first year of life was 83%, while it was only 28% between 13 and 24 months. The rate of vitamin D supplementation was higher among infants who were exclusively formula-fed (p<.05). When the data were analyzed using logistic regression analysis, only visit family physicians seems to be a statistically significant independent variable in increasing supplementation (p<.05). Compared with family refusal, the rate of discontinuation of vitamin D by the healthcare providers was higher after the first year of life (p<.05). The rates of vitamin D discontinuation by healthcare providers, especially by nurses who considered the duration of supplementation adequate, were statistically significantly higher when compared with the fontanel closure and other reasons (p<0.05). Conclusions: The rate of vitamin D supplementation was higher among families who visited family physicians, which suggests the importance of well-baby visits. Since vitamin D supplementation was less common among exclusively breastfed infants, mothers should be educated. Healthcare professionals need further education about the importance of vitamin D supplementation and indications for discontinuation.
- 15 September 2019
- Published by Medical Bulletin of Zeynep Kamil in Zeynep Kamil Tıp Bülteni
- Vol. 50 (3) , 159-161
Seyrek Görülen Bir Konjenital Hipotoni Vakası: Walker Warburg Sendromu
Konjenital muskuler distrofiler (KMD) nadir görülen, infant döneminde kas güçsüzlüğü ve motor gelişimde gecikme ile kendini gösteren bir grup hastalıktır. Bunların en ağır formlarından biri Walker Warburg Sendromu (WWS)' dur. WWS otozomal resesif geçişli, beyin ve göz anomalilerinin eşlik ettiği bir hastalıktır. Beyinde tip 2 lizensefali, beyaz cevherde hipomyelinizasyon, hidrosefali, korpus kallosum agenezisi, gözde katarakt, optik sinir displazisi, retinal displazi, lens defektleri görülür. Destek tedavisi verilse de oldukça mortal seyreder, ortalama yaşam ömrü dört ay civarındadır. Burada, klinik ve görüntüleme yöntemleriyle WWS düşünülen, kas biyopsisinde alfa distroglikan eksikliği görülerek tanısı desteklenen bir olgu sunulmuştur.
- 15 September 2019
- Published by Medical Bulletin of Zeynep Kamil in Zeynep Kamil Tıp Bülteni
- Vol. 50 (3) , 159-161
Seyrek Görülen Bir Konjenital Hipotoni Vakası: Walker Warburg Sendromu
Konjenital muskuler distrofiler (KMD) nadir görülen, infant döneminde kas güçsüzlüğü ve motor gelişimde gecikme ile kendini gösteren bir grup hastalıktır. Bunların en ağır formlarından biri Walker Warburg Sendromu (WWS)' dur. WWS otozomal resesif geçişli, beyin ve göz anomalilerinin eşlik ettiği bir hastalıktır. Beyinde tip 2 lizensefali, beyaz cevherde hipomyelinizasyon, hidrosefali, korpus kallosum agenezisi, gözde katarakt, optik sinir displazisi, retinal displazi, lens defektleri görülür. Destek tedavisi verilse de oldukça mortal seyreder, ortalama yaşam ömrü dört ay civarındadır. Burada, klinik ve görüntüleme yöntemleriyle WWS düşünülen, kas biyopsisinde alfa distroglikan eksikliği görülerek tanısı desteklenen bir olgu sunulmuştur.